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Abstract 
Background: The aim of the study was to assess gait pattern of patients diagnosed with fibromyalgia (FM) while 
performing demanding motor and/or cognitive dual tasks while walking. Further, idea was to explore possible corre-
lations of dual task gait pattern alterations to patients’ functional status and presence or absence of clinical symptoms 
associated with FM.
Methods: Twenty-four female FM patients and 24 healthy female subjects performed a basic walking task, a dual 
motor, a dual mental (cognitive) and a combined, dual motor and cognitive task simultaneously. Quantitative spatial 
(stride length) and temporal (cycle time, swing time and double support time) gait parameters were measured using 
GAITRite walkway system and their variability was assessed. Patients underwent clinical examination including assess-
ment of functional status, pain and fatigue level, psychiatric and cognitive manifestations.
Results: The motor, cognitive and combined dual tasks affect gait performance in FM patients. Difference in tasks 
between FM and healthy subjects was found as double support time prolongation. Comparison of tasks showing 
that cycle time in FM was longer than controls and stride length was shorter in patients for all conditions, while no 
changes were found in any of the gait parameters variability. Further, mental/cognitive dual tasks had a larger effect 
than motor tasks. Correlations were also found between depression and functional status of the patients and the gait 
parameters.
Conclusions: Gait is affected in FM patients while dual task walking. No changes in stride-to-stride variability point 
that patients preserve stability in complex walking situations. Analysis of gait may provide additional information for 
the FM identification based on presence of clinical features and cognitive status. Correlation of dual task gait altera-
tions with occurrence of clinical symptoms and influence of cognitive changes on gait pattern could additionally 
define FM subgroups.
Keywords: Cycle time, Stride, Gait variability, GAITRite walkway system
© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which 
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line 
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.
Introduction
Fibromyalgia (FM) is a chronic incapacitating disease 
characterized by multi-focal, widespread pain. Spectrum 
of the disease has been broadened to include symptoms 
such as tenderness, fatigue, non-refreshing sleep, mus-
culoskeletal stiffness, cognitive dysfunction, mood 
disorders, poor balance, muscle weakness, functional 
impairments and disability [1, 2]. Establishing correct 
diagnosis is still challenging due to the lack of objective 
clinical or laboratory markers, with many patients wait-
ing up to 5 years for the diagnosis. To minimize the sub-
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Gait is under strong input of cognitive functions, par-
ticularly attention and executive function [6, 7]. In addi-
tion to clinical features [8, 9] and biomarkers [10], gait 
analysis was even proposed as an objective measurement 
for quantifying and subgrouping FM patients [11, 12]. It 
was shown that gait is affected in FM patients during dual 
walking tasks [13–17]. In studies measuring gait while 
FM patients performed several motor tasks [14, 15], or 
during base walking [17–19] and walking with different 
velocities [16, 17], patients showed significant differences 
in spatio-temporal gait parameters [16–19] compared to 
healthy control subjects. Given that cognitive impairment 
in FM is one of the emerging key symptoms, quantitative 
gait analysis under motor and cognitive dual tasks could 
point toward influence of cognitive changes on gait pat-
tern. Furthermore, better understanding of gait changes 
might lead to better characterization of FM patients, and 
possibly could distinguish FM subgroups [11, 12].
Our objective was to assess quantitative spatiotempo-
ral gait parameters in female FM patients in comparison 
to healthy controls during base walk and while perform-
ing motor, cognitive and combined, both motor and 
cognitive dual tasks. Further, aim was also to explore 
possible correlations of dual task gait pattern alterations 
to patients’ functional status and presence or absence of 
clinical symptoms associated with FM.
Methods
Patients
Twenty-four female patients (mean age 
55.08 ± 11.28  years) were consecutively recruited at the 
Institute of Rheumatology, Medical faculty, University 
of Belgrade, Serbia. Patients’ diagnoses were based on 
revised diagnostic criteria for FM [5] and were regularly 
seen at the Institute for at least one year after the diag-
nosis was established. We recruited and examined 24 
consecutive patients that fulfilled inclusion/exclusion 
criteria in the period of July–December 2019. Twenty-
four healthy age and gender matched subjects (mean age 
55.17 ± 11.18 years) served as a control group (HC). HC 
were recruited among healthy employees of the Medical 
Faculty, University of Belgrade. Subjects with conditions 
that could impair independent walking (neurological 
disorders, orthopedic diseases or other medical condi-
tions, use of cane or walker) were not included. Addition-
ally, patients with major psychiatric disorders, including 
major depression were not included in the study. All 
patients were on stable treatment for at least 2  months 
prior to inclusion in the study, both fibromyalgia treat-
ment and use of antidepressant therapy, if any. The study 
was approved by Institutional Ethical Committee and 
written informed consent was obtained from each par-
ticipant prior to the inclusion in this study. The study was 
performed in accordance with the ethical standards of 
the Declaration of Helsinki and its later amendments.
Experimental protocol
Gait parameters were measured using GAITRite elec-
tronic walkway of 5.5  m (CIR Systems, Havertown, PA) 
during base walk at preferred velocity and while perform-
ing dual motor, dual mental and combined tasks [20, 21]. 
All participants performed six passes (three times down 
the pathway and back) at self-paced velocity, starting 
and ending their walks approximately 1.5  m before and 
after the walkway. Then they turn around and start their 
next pass. The motor dual task consisted of walking with 
a large (“pint”) glass which was filled with water, with 
the aim of not spilling the water. The mental/cognitive 
dual task was serial “7” subtraction while walking, start-
ing from randomly chosen numbers 90, 95 or 100. The 
combined motor and cognitive task comprised of serial 
subtractions as described, while walking with glass with 
water. The walking distance consisted of app 50  m (six 
passes × 8–9 m) for each task (basic, motor, mental, and 
combined) which finally amounted to 200 m of walking, 
sufficient to assess gait variability [20, 21].
Assessment of gait data
We measured spatiotemporal parameters—cycle time 
(CT), stride length (SL), swing time (SWT) and double 
support time (DST). Variability of gait parameters was 
calculated through the coefficient of variation (CV)—var-
iability normalized to mean value (CV = 100 × SD/mean) 
[22]. These parameters were chosen because of their 
association with executive functions, cognitive decline 
and/or gait rhythmicity in different patient and non-
patient populations [6, 7]. Data from the activated sen-
sors are collected and the GAITRite software calculated 
spatiotemporal parameters.
Assessment questionnaires
The following assessment questionnaires were used to 
estimate functional status of patients, pain and fatigue 
level, presence of depression, as well as cognitive func-
tions status. The evaluator performing clinical assess-
ments was a single, blinded, and experienced physician/
rheumatologist.
Fibromyalgia Impact Questionnaire Revised (FIQR)
The FIQR is the instrument for measuring functional sta-
tus in FM patients. It includes 21 items that are answered 
on numeric rating scale of 0-to-10, with 10 reflecting 
greatest impairment. The time frame is the 7 days, with 
the items distributed across three associated domains: 
“function” (9 items); “overall impact” (2 items); and 
“severity of symptoms” (10 items). The scoring system 
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is as follows: the physical function domain (0-to-90) is 
divided by 3, the overall impact domain (0-to-20) is not 
transformed, and the severity of symptoms domain (0-to-
100) is divided by 2 [23].
Krupp Fatigue Severity Score (FSS)
Severity and impact of fatigue was measured by FSS 
[24]. Patients were asked to rate their level of agreement 
(toward seven) or disagreement (toward zero) with nine 
statements. A score of 36 and above (out of a maximum 
of 63) indicated the presence of significant fatigue. A 
higher score indicates greater fatigue. FSS is most effec-
tive as a measure of disability-related fatigue arising from 
a chronic, debilitating illness.
Visual Analog Scale of pain intensity
The visual analog scale (VAS) is a validated, subjective 
measure for acute and chronic pain. Scores are recorded 
by making a handwritten mark on a 10-cm line that rep-
resents a continuum between “no pain” and “worst pain” 
(or more precisely between 0 and 100%).
The Short Form (36) Health Survey
All patients completed the SF-36 questionnaire as a 
measure of health related quality of life [25]. The SF-36 
is a generic instrument that measures eight general 
health concepts: physical functioning (PF), role physical 
(RP), bodily pain (BP), general health (GH), vitality (VT), 
social functioning (SF), role emotional (RE) and mental 
health (MH). Two main scores are available to summarize 
these scales: physical composite score (PCS) and mental 
composite score (MCS), as well as total SF-36 score. All 
these scores fall within a 0–100 scale, with higher scores 
reflecting better health related quality of life.
Euroqol 5 dimensions (EQ 5D 3L)
All patients completed the 3-level version of EuroQol 5 
dimensions (EQ-5D-3L). The EQ-5D-3L essentially con-
sists of 2 pages: the EQ-5D descriptive system and the 
EQ visual analogue scale (EQ VAS). The first part records 
the severity of the problem in each of the five dimen-
sions, and the second part contains a 20-cm vertical 
visual analogue scale ranging from 0 to 100, where 0 cor-
responds to the worst imaginable health states and 100 
corresponds to the best health states. Its five dimensions 
are mobility, self-care, usual activities, pain/discomfort, 
and anxiety/depression, and each dimension has three 
levels of severity (no problems, moderate problems, and 
extreme problems). Health status is labeled with a five-
digit number that represents the severity level in each 
dimension [26].
Mini Mental State Examination (MMSE)
The MMSE is an 11-question assessment tool to test 
domains—orientation of time and place, registration of 3 
words, attention and calculation (recall of 3 words, lan-
guage and visual construction). The test is scored from 0 
to 30, where higher scores indicate better cognitive per-
formance, and a score below 24 suggests dementia [27].
Hamilton Depression Rating Scale (HAM‑D)
This 17-item scale questioning the depressive complaints 
in the past week. The maximum score is 53 points. The 
scoring is as follows: 0–7 points indicates “no depression”, 
8–15 points indicates “mild depression”, 16–28 points 
indicates “moderate depression”, 29 points and above 
indicates “severe depression” [28].
Beck’s Depression Inventory (BDI)
Beck’s Depression Inventory was used to assess the mood 
[29]. This index is a validated instrument which includes 
21 items measuring depression. Scores above 13 are indi-
cating the presence of depression and scores above 21 to 
indicate major depression.
Statistical analysis
Shapiro–Wilk test was used for data normality assess-
ment. Friedman test was used to analyze statistical sig-
nificance through motor, cognitive and combined tests 
input within groups (FM and HC). The independent 
t-test was performed for CT, SL, SWT and DST (para-
metric variables) while Mann–Whitney test (non-para-
metric) were performed for CV CT, CV SL, CV SWT and 
CV DST while FM and HC walking during different con-
ditions. According to data obtained by normality tests, 
we used Spearman’s (rho) correlation coefficient.
The analyses were performed using SPSS 17.0 (SPSS, 
Chicago, IL), and p-values < 0.05 were considered 
significant.
Results
We included 24 female FM patients (mean age 
55.08 ± 11.28  years) and 24 healthy controls (mean age 
55.17 ± 11.18  years). Demographic and clinical features 
of patients are presented in Table 1.
Patients were on average in the range of mild depres-
sion, according to HAM-D (15.63 ± 6.03) and BDI 
(14.63 ± 6.36). During evaluation, 11 patients (45.8%) 
reported use of antidepressant therapy.
Gait parameters of FM patients and healthy control 
subjects (cycle time, stride length, swing time and dou-
ble support time, and CVs of those parameters) were pre-
sented for all experimental conditions during base walk, 
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dual motor task, dual mental task and combined task in 
Fig. 1 (gait parameters on left panels, their CVs on right 
panels).
Assessing the impact of motor, cognitive and combined 
tasks in all subjects, FM patients and HC, confirmed that 
these tasks affect gait performance (Friedman test). There 
were no differences in within group comparisons of FM 
patients and HCs in any of the assessed parameters, 
except in double support time during combined task, 
which was significantly prolonged in FM patients com-
pared to HC (Fig. 1—* represents significance p = 0.022).
Between group comparisons showed that cycle time 
of FM patients was significantly longer than in HC while 
stride length was shorter in patients for all four walking 
conditions. Swing time was prolonged in FM patients 
compared to HC for base and motor tasks, while double 
support time was significantly different for motor, men-
tal and combined tasks (see Table 2, all significant differ-
ences are italic values). Further, note that CV’s of all gait 
parameters were not significantly different in FM com-
pared to HC in any of the walking conditions.
There was no correlation of VAS, FSS, MMSE, SF 36 
physical, SF 36 total and FIQR with any of the four gait 
parameters and their CVs, performed in any of four walk-
ing tasks for FM patients. BDI correlate to cycle time, 
stride length and double support time while performing 
combined task (ρ = 0.58, p < 0.01; ρ = − 0.5, p < 0.05 and 
ρ = 0.58, p < 0.01, respectively). In FM patients HAM-D 
correlate to stride length and double support time. 
Correlations were also found in six other CVs of gait 
parameters through all four tasks (see details in Table 3). 
Concerning EQ 5D 3L, we found correlation for SWT 
and CV SWT and CV DST in most of the walking tasks, 
respectively. Correlations of SF 36 mental are also shown 
in Table 3.
Discussion
Study findings indicate that gait was impaired in FM 
patients, and gait performance correlates to clinical 
symptoms associated with fibromyalgia. Compared to 
their matched HC, FM female patients have shown sig-
nificant differences in spatio-temporal gait parameters 
(CT, SL, SWT and DST) while their CV’s were not sig-
nificantly different in any of the walking conditions. 
Those findings were different to earlier literature findings 
[16–18].
In studies measuring gait while female FM patients per-
formed several motor tasks [14, 15], or during base walk-
ing [17] and walking with different velocities [16, 17], 
results did not support gender-specific differences [16]. 
In general, women with FM have lower pain thresholds, 
greater diffuse pain, a higher number of tender points, 
higher levels of fatigue and greater sleep disturbance 
compared to men with FM [30–33]. However, differences 
in spatio-temporal gait variables were not reported [16–
19]. Therefore, our study with only female patients could 
give conclusions irrespective of patients’ gender, while 
making patient group more coherent concerning gait 
characteristics.
Our patients were in the range of mild depression 
(Table 1). It was shown earlier that gait in patients with 
depression is affected in a certain manner [e.g., 20, 34]. 
In our earlier study with very similar protocol, patients 
with major depression demonstrated slower gait in all 
task conditions compared to HC, while maintaining sta-
bility. Tasks that required greater cognitive involvement 
increased gait variability in patients, but only up to a 
certain level, after which patients’ gait stability appeared 
unaffected by the increase of cognitive demand [20]. Gait 
in FM patients is affected similarly, showing similar pat-
tern of gait parameters changes as described for patients 
with depressive disorder [20]. That could point toward 
important influence of depressive symptoms in FM on 
gait. Further, it is interesting that HAM-D scores nega-
tively correlated to stride length in all conditions while 
were positively associated to DST only where cognitive 
input was engaged (i.e. mental and combined tasks). BDI 
correlated to CT, SL and DST only during combined, 
more complex tasks. It could be speculated that symp-
toms of depression influence patients to reduce stride 
length and double support time in comparison to their 
matched control subjects, such a measures to preserve 
stability of gait, mostly affected while cognitive, mental 
Table 1 Demographic and Clinical features of fibromyalgia 
patients (n=24)
Values present means ± SDs—FIQR: Fibromyalgia Impact Questionnaire Revised; 
FSS: Krupp’s Fatigue Severity Scale; VAS: visual analog scale; SF 36 PCS: The Short 
Form (36) Health Survey: physical composite score; SF 36 MCS: The Short Form 
(36) Health Survey—mental composite score; SF 36 total: The Short Form (36) 
Health Survey total score; EQ 5D 3L: Euroqol 5 dimensions 3-level version; HAM-
D: Hamilton Depression Rating Scale; MMSE: Mini Mental State Examination; BDI: 
Beck Depression Inventory
Value Mean ± SD
Disease duration (years) 11.72 ± 8.59
Time from diagnosis (years) 4.75 ± 3.42
FIQR 50.68 ± 18.20
FSS 4.77 ± 1.65
VAS 66.25 ± 18.84
SF 36 PCS 35.83 ± 14.85
SF 36 MCS 46.29 ± 19.23
SF 36 total 41.12 ± 16.84
EQ 5D 3L 62.92 ± 22.55
MMSE 29.00 ± 1.35
HAM-D 15.63 ± 6.03
BDI 14.63 ± 6.36
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Fig. 1 Comparison between FM patients (circle) and control subjects (square). Four left panels represent FM cycle time, stride length, swing time 
and double support time compared to controls, while four right panels represent the CV’s of cycle time, stride length, swing time and double 
support time. Patients and controls performing the following tasks: base walk (B), motor task (M), cognitive task (7) and combined motor and 
cognitive tasks (C). Each symbol represents the mean values. Note panel Double support time—*represents significance (Mann Whithey U test, 
p = 0.022)
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tasks requirements were employed. That might prevent 
negative cognitive input on gait stability, shortening the 
strides and increasing time with both feet on the ground, 
reducing gait variability in such complex situations. 
However, our patients were not suffering from major 
depression and were on stable antidepressant treatment, 
suggesting possible impact of FM per se.
Patients’ gait is examined under dual task conditions, 
and possible impairments in dual task walking are esti-
mated in relation to mental/cognitive and motor engage-
ment. CT and SL were different between FM and HC 
for all experimental conditions (Table  2). Further, SWT 
was different in base and motor tasks, while it was not 
different during mental and combined tasks. That find-
ing could mean that FM patients behave differently from 
HC, and during tasks without cognitive employment, 
their gait pattern is changed. The parameters affected 
by base walk or motor performance might be linked to 
clinical symptoms associated with FM, such as presence 
of chronic pain, bradykinesia, stiffness or fatigue [13–
15, 17], and that could be responsible for gait altera-
tions. Further, tasks with cognitive inputs (mental and 
combined) show no significant influence. That could be 
explained by importance and strong input of cognition 
on gait, on both groups, where HC also change their gait 
pattern while performing a secondary mental task [e.g., 7, 
35, 36] (Table 2, Fig. 1). Additional tasks did not signifi-
cantly affect described gait parameters changes, changes 
are already present, to preserve stability. Additionally, 
FM patients had considerable prolongation of DST while 
performing combined task (Table 2 and Fig. 1), stressing 
certain level of postural instability [37]. Since swing time 
and double support time were reported to reflect pos-
ture and balance [7, 21, 37], that could be the action to 
increase stability due to increased attention and aware-
ness of patients of requirement to fulfill the complex 
given tasks. On the other hand, gait variability was not 
significantly increased as earlier described in the study 
Table 2 Between group comparisons (FM vs HC) of gait parameters for all experimental conditions
CT Cycle Time, SL Stride Length, SWT Swing Time, DST Double support time, CV Coefficient of variation
CT SL SWT DST CV CT CV SL CV SWT CV DST
Base walk 0.001 0.003 0.032 0.149 0.248 0.303 0.837 0.621
Motor task 0.001 0.003 0.041 0.039 0.103 0.103 0.398 0.711
Mental task 0.005 0.003 0.125 0.038 0.266 0.138 0.293 0.564
Combined task 0.006 0.009 0.123 0.014 0.278 0.120 0.090 0.334
t test Mann–Whitney test
Table 3 Correlations of HAM-D, EQ-5D-3L and SF 36m to gait parameters in all walking tasks
HAM-D: Hamilton Depression Rating Scale; EQ 5D 3L: Euroqol 5 dimensions 3-level version; SF 36m: The Health Survey Mental composite score. Correlations of other 
used assessment questionnaires and gait parameters were described in Result section.
ρ (rho) = Spearman correlation, *p < 0.05, **p < 0.01
CT SL SWT DST CV CT CV SL CV SWT CV DST
HAM-D
Base walk 0.13 − 0.4* − 0.34 0.35 0.49* 0.46* 0.29 0.21
Motor task 0.39 − 0.42* − 0.34 0.36 0.48* 0.29 0.32 0.15
Mental task 0.35 − 0.5* − 0.11 0.51* 0.26 0.36 0.58** 0.42*
Combined task 0.41 − 0.58** 0.20 0.69** 0.32 0.32 0.58** 0.31
EQ 5D 3L
Base walk 0.19 0.06 0.57** − 0.20 − 0.27 − 0.04 0.44* − 0.59**
Motor task 0.28 0.07 0.49* − 0.15 − 0.40 − 0.01 − 0.43* − 0.45*
Mental task 0.12 0.13 0.32 − 0.11 − 0.21 − 0.13 − 0.61** 0.5*
Combined task − 0.05 − 0.27 0.49* − 0.30 − 0.21 − 0.13 − 0.55* − 0.48*
SF 36m
Base walk 0.05 0.35 0.28 − 0.19 − 0.40 − 0.33 − 0.25 − 0.34
Motor task − 0.07 0.32 0.18 − 0.14 − 0.43* − 0.18 − 0.23 − 0.23
Mental task − 0.16 0.38 0.2 − 0.25 − 0.36 − 0.37 − 0.53** − 0.42*
Combined task − 0.41 0.55* 0.18 − 0.55* − 0.35 − 0.41 − 0.46* − 0.31
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where FM females were tested [17], but trend of greater 
CVs across all tasks was observed that did not reach sta-
tistical significance, possibly due to smaller sample in our 
study. Alternatively, our patients tend to preserve stabil-
ity in those dual tasks, complex walking situations.
In order to assess the influence of the disease clinical 
characteristics, we correlated gait parameters in all exper-
imental conditions to the questionnaires and patients’ 
reports. There were no significant correlation of VAS, 
FSS, MMSE, SF 36 physical, SF 36 total and FIQR with 
any of the four gait parameters and their CVs, performed 
in any of four walking tasks for FM patients. Correlates of 
depression status (BDI and HAM-D) are particularly pre-
sent for stride length, and that was discussed earlier. Cor-
relations of EQ 5D 3L and SF 36m—severity of the health 
status and quality of life in the domain of mental health 
with evaluated gait parameters are shown in Table  3. 
Most of the correlations were with the parameters SWT, 
CV of SWT and DST. As it was said earlier, swing time 
and double support time were reported to reflect posture 
and balance, possibly as a function of preserved central 
mechanisms [7, 21, 37]. Therefore our patients preserve 
gait stability and adapt gait pattern for complex require-
ments while walking, probably because of their perceived 
deteriorated health status and its mental component that 
could change gait and evoke walking instability. Atten-
tion should be paid to depression status of FM patients 
in order to either improve gait pattern or to use that tests 
to define FM subgroup and focus on treatment of depres-
sion. Same is true for assessment of severity of the per-
ceived health status (e.g. EQ 5D 3L) and quality of life 
patients’ experiencing, especially in the domain of mental 
health (e.g. SF 36m).
Limitation of the study was the design where we per-
formed single center, observational, cross-sectional study 
and we could suggest that longitudinal studies would 
strengthen the study findings and recommendations. 
Also, lower prevalence of FM in man limited us to per-
form study in female patients only. Finally, the number of 
our female patients took antidepressant medication and, 
therefore, the effect of this medication on gait character-
istics could not be completely neglected.
Conclusions
It could be concluded that gait is affected in FM patients 
during dual walking tasks. Cognitive tasks, alone or com-
bined with motor task, had a larger effect than motor 
tasks. However, no changes in stride-to-stride variabil-
ity indicated that patients preserve stability in complex 
walking situations, in spite of potential clinical symp-
toms effect. Therefore, analysis of gait may provide 
additional information for the FM identification based 
on presence of certain clinical symptoms and cognitive 
status. Attention also should be paid to depression status 
of patients to either improve gait pattern or to use that 
tests to define FM subgroups. According to these results 
we could further support the approach that correlation 
of dual task gait pattern alterations to existence of FM 
symptoms and cognitive changes influencing gait pattern 
could successfully define FM subgroups.
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